FDA Adverse Event Malfunction Summary report: N

SEE H10

MDR report key: 4439400 · Received January 21, 2015

Report

Report Number
2015691-2015-00140
Event Type
Malfunction
Date Received
January 21, 2015
Date of Event
December 9, 2014
Report Date
December 22, 2014
Manufacturer
EDWARDS LIFESCIENCES
Product Code
DYE
PMA / PMN Number
SEE H10
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE IS NOT SOLD OR MARKETED IN THE UNITED STATES; HOWEVER, IT IS SIMILAR TO THE BRAND CARPENTIER-EDWARDS DURAFLEX LOW PRESSURE MITRAL BIOPROSTHESIS, MODEL# 6625-LP, PMA# P870077. METHOD: DEVICE REMAINS IMPLANTED. ADDITIONAL MANUFACTURER NARRATIVE THE DEVICE WAS NOT RETURNED TO EDWARDS FOR ANALYSIS AS THIS REMAINS IMPLANTED IN THE PATIENT. WITHOUT RETURN OF THE DEVICE, EDWARDS IS UNABLE TO CONCLUSIVELY DETERMINE THE ROOT CAUSE FOR THIS EVENT, OR CONFIRM THE CLINICAL OBSERVATION. AT THIS TIME, NO ADDITIONAL INFORMATION HAS BEEN OBTAINED WHICH INDICATES THE PATIENT HAS UNDERGONE INTERVENTION FOR THE FAILING SURGICAL VALVE. IF FURTHER INFORMATION BECOMES AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

ADDITIONAL MANUFACTURER NARRATIVE: NO DEFINITIVE CONCLUSIONS CAN BE DRAWN REGARDING THE CLINICAL OBSERVATION. THE DEVICE HISTORY RECORD (DHR) REVIEW WAS COMPLETED AND THIS DEVICE PASSED ALL MANUFACTURING AND STERILIZATION INSPECTIONS. EDWARDS WILL CONTINUE TO REVIEW AND MONITOR ALL EVENTS. TRENDS ARE MONITORED ON A MONTHLY BASIS AND IF ACTION IS REQUIRED, APPROPRIATE INVESTIGATION WILL BE PERFORMED.

Description of Event or Problem · 1

EDWARDS RECEIVED ADDITIONAL INFORMATION THAT THIS FAILING SURGICAL MITRAL VALVE UNDERWENT INTERVENTION WITH PLACEMENT OF A TRANSCATHETER VALVE (VALVE-IN-VALVE).

Description of Event or Problem · 1

EDWARDS RECEIVED INFORMATION THAT THIS SURGICAL MITRAL VALVE IS FAILING DUE TO MITRAL REGURGITATION CAUSED BY STRUCTURAL VALVE DEGENERATION. THE IMPLANT DURATION OF THE SURGICAL VALVE IS APPROXIMATELY ELEVEN (11) YEARS. AS REPORTED, INTERVENTION HAS YET TO TAKE PLACE; HOWEVER, THE PATIENT IS SCHEDULED TO UNDERGO VALVE-IN-VALVE INTERVENTION. NO ADDITIONAL DETAILS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
50185 SEE H10 REPLACEMENT HEART VALVE DYE EDWARDS LIFESCIENCES SEE H10

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R